Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.

  • Authors : Lassaletta A; Alvaro Lassaletta, Cynthia E. Hawkins, Rahul Krishnatry, Matthew Mistry, Anthony Arnoldo, Vijay Ramaswamy, Annie Huang, Ute Bartels, Uri Tabori, and Eric Bouffet, The Hospital for Sick Children, Toronto; Katrin Scheinemann, McMaster Children's Hospital

Subjects: Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*administration & dosage ; Astrocytoma/Astrocytoma/Astrocytoma/*drug therapy ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Oct 10; Vol. 34 (29), pp. 3537-3543.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

×
Academic Journal

Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.

  • Authors : Keller AM; US Oncology Inc, Cancer Care Associates, 6151 S Yale, Tulsa, OK 74136, USA. ; Mennel RG

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Bridged-Ring Compounds/Bridged-Ring Compounds/Bridged-Ring Compounds/*therapeutic use ; Doxorubicin/Doxorubicin/Doxorubicin/*therapeutic use

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Oct 01; Vol. 22 (19), pp. 3893-901.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

×
Academic Journal

Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.

  • Authors : Siefker-Radtke AO; Center for Genitourinary Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; Millikan RE

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cisplatin/Cisplatin/Cisplatin/*therapeutic use ; Doxorubicin/Doxorubicin/Doxorubicin/*therapeutic use M-VAC protocol

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2002 Mar 01; Vol. 20 (5), pp. 1361-7.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

×
Academic Journal

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Subjects: Taxoids*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1999 May; Vol. 17 (5), pp. 1413-24.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

×
Academic Journal

Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant.

  • Authors : Little R; Medicine Branch, National Cancer Institute, Bethesda, MD 20892, USA.; Wittes RE

Subjects: Bone Marrow Transplantation*; Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*therapeutic use ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1998 Feb; Vol. 16 (2), pp. 584-8.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

×
Academic Journal

Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

  • Authors : Bouffet E; Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. ; Jakacki R

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Glioma/Glioma/Glioma/*drug therapy ; Glioma/Glioma/Glioma/*mortality

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2012 Apr 20; Vol. 30 (12), pp. 1358-63. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

×
Academic Journal

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.

  • Authors : Le Deley MC; Biostatistics and Epidemiology Unit, Institut Gustave-Roussy, Villejuif, France. ; Rosolen A

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Vinblastine/Vinblastine/Vinblastine/*administration & dosage; Adolescent

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Sep 01; Vol. 28 (25), pp. 3987-93. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

×
Academic Journal

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Lymphoma, Large-Cell, Anaplastic/Lymphoma, Large-Cell, Anaplastic/Lymphoma, Large-Cell, Anaplastic/*drug therapy ; Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/*drug therapy

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2009 Oct 20; Vol. 27 (30), pp. 5056-61. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

×
Editorial & Opinion

How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Bleomycin/Bleomycin/Bleomycin/*therapeutic use ; Dacarbazine/Dacarbazine/Dacarbazine/*therapeutic use ABVD protocol

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Apr 15; Vol. 22 (8), pp. 1532-3.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

×
  • 1-10 of  571 results for ""Vinblastine""